new glp 1 agonist for weight loss GLP-1s Loss: What You Need to Know Frontiers | GLP−1 receptor agonists

Many of these incidents involved dosing errors that resulted in hospital visits

Trial of lixisenatide in early Parkinsons disease

Pharmacies must balance supply across patients using these drugs for diabetes and those using them for weight loss, often under conditions where availability, while improved compared to earlier shortages, is still uneven at the local level

In its initial announcements, CMS indicated that the GLP-1 Bridge program would run from July 1, 2026, through the end of the year, with the BALANCE Model beginning in January 2027

First submitted to a journal in 1989, the article was finally published in 1992